Key Factor Supporting Global Sarcopenia Treatment Market Development in 2025: Surge In Malnutrition Boosts Sarcopenia Treatment Market Growth

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Sarcopenia Treatment Market Size By 2025?
The market dedicated to sarcopenia treatments has witnessed robust expansion over the past few years, projected to escalate from a valuation of $3.52 billion in 2024 to $3.72 billion a year later, reflecting a compound annual growth rate of 5.8%; this upward trajectory during the review period is attributable to several factors, including the increasing global elderly demographic, heightened recognition and identification of the condition, shifts in societal behaviors and habits, proactive governmental health campaigns, and the securing of new regulatory clearances.

How Big Is the Sarcopenia Treatment Market Size Expected to Grow by 2029?
Projections indicate vigorous expansion for the sarcopenia treatment market in the impending years, reaching a valuation of $4.69 billion by 2029, propelled by a compound annual growth rate (CAGR) of 6.0%; this upward trajectory is fundamentally supported by advancements such as tailored medicinal approaches, dietary strategies, the deployment of digital wellness systems, enhanced patient knowledge and autonomy, and worldwide health campaigns, while key developments shaping this era involve individualized treatments, the introduction of entirely new pharmaceutical categories, the merging of digital healthcare solutions, joint research efforts, and sustained research and development activities.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report

Which Key Market Drivers Powering Sarcopenia Treatment Market Expansion and Growth?
Anticipated escalation in malnutrition ought to fuel the expansion of the market for sarcopenia treatments in the future. Malnutrition encompasses instances where energy and nutrient consumption is either insufficient, excessive, or unbalanced, spanning conditions from undernourishment to obesity and diet-linked chronic illnesses. Interventions designed to manage sarcopenia concurrently target associated malnutrition issues in the elderly population; these might include dietary adjustments and physical activity programs intended to boost muscle bulk, enhance strength, and generally better an individual's nutritional standing. As an illustration, data released in December 2023 by the World Health Organization (WHO), a United Nations agency headquartered in Switzerland, highlighted that malnutrition persists as a major worldwide health concern, noting that approximately 462 million individuals were underweight and 149 million youngsters under the age of five exhibited stunting in the year 2022. Consequently, the increasing prevalence of malnutrition serves as a catalyst for the market expansion of sarcopenia treatments.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13926&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Sarcopenia Treatment Market?
Key players within the sarcopenia therapeutics sector are intensifying their efforts on creating several cutting-edge clinical trials to establish superior treatment modalities. Such a clinical trial represents a structured research endeavor involving human participants, designed to ascertain the safety, effectiveness, and/or results stemming from a particular medical intervention. As an illustration, in the month of September in 2023, Biophytis, a biotech firm originating from France, secured United States Food and Drug Administration (FDA) clearance to commence the SARA-31 Phase 3 investigation targeting sarcopenia. This particular trial is set to examine how well Sarconeos (BIO101) performs in terms of both efficacy and safety when administered to sarcopenic individuals facing the threat of motor impairment. This initiative underscores a major leap forward in pharmaceutical and technological strategies for treatment, potentially bringing forth notable advantages in terms of effect and safety profile for individuals suffering from advanced sarcopenia, and notably marks the inaugural Phase 3 trial in this condition to gain FDA sanctioning. The trial is projected to enroll approximately 900 individuals over the age of 65 who have been diagnosed with sarcopenia, exhibiting diminished walking speed and reduced grip strength, with the main objectives centering on measuring the probability of experiencing major mobility disability (MMD), evaluating gait velocity, assessing hand grip strength metrics, and tracking the quality of life as reported by the patients themselves.

What Are the Emerging Segments in the Sarcopenia Treatment Market?
The sarcopenia treatmentmarket covered in this report is segmented -

1) By Treatment Type: Protein Supplements; Vitamin B12 Supplements; Vitamin D And Calcium Supplements; Other Treatment Types
2) By Type: Primary Sarcopenia; Secondary Sarcopenia
3) By Route Of Administration: Oral; Parenteral; Enteral
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels

Subsegments:
1) By Protein Supplements: Whey Protein; Casein Protein; Soy Protein; Plant-Based Protein
2) By Vitamin B12 Supplements: Cyanocobalamin; Methylcobalamin
3) By Vitamin D And Calcium Supplements: Vitamin D2; Vitamin D3; Calcium Carbonate; Calcium Citrate
4) By Other Treatment Types: Exercise Programs; Hormone Replacement Therapy; Other Nutritional Interventions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13926&type=smp

Who Are the Global Leaders in the Sarcopenia Treatment Market?
Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill

Which are the Top Profitable Regional Markets for the Sarcopenia Treatment Industry?
North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13926

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.